Find disease awareness content and relevant supporting materials

The PRIME trial provides evidence for biparametric MRI as a new standard-of-care alternative to multiparametric MRI in prostate cancer diagnosis.

Israel publishes updated national guidelines for the diagnosis, treatment, and long‑term management of myasthenia gravis. The guidance standardizes diagnostic workup, antibody‑based treatment strategies, thymectomy timing, and care for special populations to reduce practice variability and improve outcomes.

The Portuguese Neuromuscular Society publishes consensus guidelines on the diagnosis and treatment of myasthenia gravis. The guidance provides step‑by‑step diagnostic workup, antibody‑based classification, and tailored treatment algorithms incorporating newer targeted therapies.

Some cancer therapies may be more effective when given earlier in the day, aligning treatment with the body's natural rhythms, a Chinese study found, confirming earlier evidence.

Apple watches are proving useful in screening for the common heart rhythm disorder atrial fibrillation, or AFib, according to two studies published in the Journal of the American College of Cardiology.

Practical guidance on HRR testing and therapy

From diagnostic delays to therapy decisions

Women vaccinated against the human papillomavirus can safely skip many of the cervical cancer screenings that are typically recommended every three to five years, a new study from Norway suggests.

Find out more about the Asia-Pacific Academy of Opthalmology and related resources for healthcare professionals.

The Brazilian Association of Otorhinolaryngology and Cervicofacial Surgery updates its guideline on the use of immunobiologicals for chronic rhinosinusitis with nasal polyps. The 2024 update introduces a structured eligibility model to support patient selection and optimize outcomes within the Brazilian healthcare system.